Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wilcox

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infectionG Ralph Corey, Mark Wilcox, George H Talbot, et al.
BMC Infectious Diseases|July 27, 2020
Modifiable healthcare factors affecting 28-day survival in bloodstream infection: a prospective cohort studyRebecca N Evans, Katie Pike, Chris A Rogers, et al.
Frontiers in Medicine|January 30, 2023
Improving care for patients with <i>Clostridioides difficile</i> infection: A clinical practice and healthcare systems perspectiveLucy Hocking, Mark Wilcox, Nicola Petrosillo, et al.
The Lancet. Infectious Diseases|January 29, 2008
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statementIan Chopra, Christopher Schofield, Martin Everett, et al.
Plos One|September 14, 2017
Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in ColombiaClara Lina Salazar, Catalina Reyes, Santiago Atehortua, et al.
Pharmacoeconomics|April 7, 2020
Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission ModelJason Gordon, Oliver Darlington, Phil McEwan, et al.
Jac-Antimicrobial Resistance|July 24, 2024
Antimicrobial susceptibility in <i>Clostridioides difficile</i> varies according to European region and isolate sourceJane Freeman, Virginie Viprey, Duncan Ewin, et al.
Emerging Microbes & Infections|November 13, 2024
Distribution of <i>Clostridioides difficile</i> ribotypes and sequence types across humans, animals and food in 13 European countriesMaja Rupnik, Virginie Viprey, Sandra Janezic, et al.
Annals of the Royal College of Surgeons of England|January 8, 2009
A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resectionAhmed Al-Mukhtar, Vincent K H Wong, Hassan Z Malik, et al.
International Journal of Antimicrobial Agents|April 14, 2015
Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up surveyMatthew Dryden, Arjana Tambic Andrasevic, Matteo Bassetti, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infectionG Ralph Corey, Mark Wilcox, George H Talbot, et al.
BMC Infectious Diseases|July 27, 2020
Modifiable healthcare factors affecting 28-day survival in bloodstream infection: a prospective cohort studyRebecca N Evans, Katie Pike, Chris A Rogers, et al.
Frontiers in Medicine|January 30, 2023
Improving care for patients with <i>Clostridioides difficile</i> infection: A clinical practice and healthcare systems perspectiveLucy Hocking, Mark Wilcox, Nicola Petrosillo, et al.
The Lancet. Infectious Diseases|January 29, 2008
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statementIan Chopra, Christopher Schofield, Martin Everett, et al.
Plos One|September 14, 2017
Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in ColombiaClara Lina Salazar, Catalina Reyes, Santiago Atehortua, et al.
Pharmacoeconomics|April 7, 2020
Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission ModelJason Gordon, Oliver Darlington, Phil McEwan, et al.
Jac-Antimicrobial Resistance|July 24, 2024
Antimicrobial susceptibility in <i>Clostridioides difficile</i> varies according to European region and isolate sourceJane Freeman, Virginie Viprey, Duncan Ewin, et al.
Emerging Microbes & Infections|November 13, 2024
Distribution of <i>Clostridioides difficile</i> ribotypes and sequence types across humans, animals and food in 13 European countriesMaja Rupnik, Virginie Viprey, Sandra Janezic, et al.
Annals of the Royal College of Surgeons of England|January 8, 2009
A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resectionAhmed Al-Mukhtar, Vincent K H Wong, Hassan Z Malik, et al.
International Journal of Antimicrobial Agents|April 14, 2015
Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up surveyMatthew Dryden, Arjana Tambic Andrasevic, Matteo Bassetti, et al.
Pageof 8